CMS Keeps Pace With FDA, Rethinks Payments For Reprocessed Devices
This article was originally published in The Gray Sheet
Hospitals seeking reimbursement for reprocessed single-use devices under Medicare's outpatient prospective payment system (OPPS) will be obliged to demonstrate cost savings to CMS.
You may also be interested in...
Third-party reprocessors may lack the capacity to fulfill the demands of hospitals unable to comply with FDA's regulatory requirements for single-use devices (SUDs), scheduled to take effect Aug. 14.
Hanmi showcases at JPM its contract production capabilities for COVID-19 vaccines as South Korea prepares to bring in candidates from several global developers, while LG Chem highlights progress across multiple pipeline projects.
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker